valsartan has been researched along with Hyperemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, T; Hirakawa, N; Kamezaki, F; Kouzuma, R; Nagatomo, T; Otsuji, Y; Shibata, K; Tasaki, H; Tsutsui, M; Yamashita, K | 1 |
| Koji, Y; Shiina, K; Tomiyama, H; Yamada, J; Yamashina, A; Yoshida, M | 1 |
2 trial(s) available for valsartan and Hyperemia
| Article | Year |
|---|---|
Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Echocardiography; Female; Humans; Hyperemia; Hypertension; Male; Middle Aged; Nifedipine; Tetrazoles; Valine; Valsartan | 2007 |
Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Endothelium, Vascular; Female; Forearm; Humans; Hyperemia; Hypertension; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |